Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Martina Porstner"'
Autor:
Focke Ziemssen, Hansjürgen Agostini, Nicolas Feltgen, Robert P. Finger, Christos Haritoglou, Hans Hoerauf, Matthias Iwersen, Martina Porstner, Andreas Clemens, Benjamin Gmeiner
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Neovascular age-related macular degeneration (nAMD) is a progressive retinal disease that often leads to severe and permanent vision loss. Early initiation of anti-vascular endothelial growth factor (anti-VEGF) therapy has been shown to pres
Externí odkaz:
https://doaj.org/article/bbd635caba394520bf94b6167c71da92
Autor:
Claudia Sommerer, Oliver Witzke, Frank Lehner, Wolfgang Arns, Petra Reinke, Ute Eisenberger, Bruno Vogt, Katharina Heller, Johannes Jacobi, Markus Guba, Rolf Stahl, Ingeborg A. Hauser, Volker Kliem, Rudolf P. Wüthrich, Anja Mühlfeld, Barbara Suwelack, Michael Duerr, Eva-Maria Paulus, Martin Zeier, Martina Porstner, Klemens Budde, on behalf of the ZEUS and HERAKLES study investigators
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-13 (2018)
Abstract Background Conversion from calcineurin inhibitor (CNI) therapy to a mammalian target of rapamycin (mTOR) inhibitor following kidney transplantation may help to preserve graft function. Data are sparse, however, concerning the impact of conve
Externí odkaz:
https://doaj.org/article/03ee2b06a3cf4b8ba50f0091731a8e25
Autor:
Ute Eisenberger, Klemens Budde, Frank Lehner, Claudia Sommerer, Petra Reinke, Oliver Witzke, Rudolf P. Wüthrich, Rolf Stahl, Katharina Heller, Barbara Suwelack, Anja Mühlfeld, Ingeborg A. Hauser, Silvio Nadalin, Martina Porstner, Wolfgang Arns, on behalf of the ZEUS Study Investigators
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background Conversion from calcineurin inhibitor (CNI) therapy to everolimus within 6 months after kidney transplantation improves long-term graft function but can increase the risk of mild biopsy-proven acute cellular rejection (BPAR). We p
Externí odkaz:
https://doaj.org/article/fbf607c0b5f54c4eb561eba8de23ad05
Autor:
Susanne Brakemeier, Wolfgang Arns, Frank Lehner, Oliver Witzke, Oliver Vonend, Claudia Sommerer, Anja Mühlfeld, Thomas Rath, Robert Schuhmann, Bianca Zukunft, Irena Kroeger, Martina Porstner, Klemens Budde
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222730 (2019)
Early conversion to everolimus was assessed in kidney transplant recipients participating in the Eurotransplant Senior Program (ESP), a population in whom data are lacking. The SENATOR multicenter study enrolled 207 kidney transplant recipients under
Externí odkaz:
https://doaj.org/article/eaa6a2e38f724ec4bbed41d38eb07d26
Autor:
Ingeborg A. Hauser, Martina Sester, Barbara Suwelack, Björn Nashan, Claudia Sommerer, Christiane Schiedel, Friedrich Thaiss, Frank Lehner, Oliver Witzke, Stefanie Marx, C. Neudörfl, Christine S. Falk, Duska Dragun, Martina Porstner
Publikováno v:
European Journal of Immunology. 51:943-955
Post-transplant cytomegalovirus (CMV) infections and increased viral replication are associated with CMV-specific T-cell anergy. In the ATHENA-study, de-novo everolimus (EVR) with reduced-exposure tacrolimus (TAC) or cyclosporine (CyA) showed signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80c66dd8da8acd892a717edda4b4d6fb
https://doi.org/10.1002/eji.202048855
https://doi.org/10.1002/eji.202048855
Autor:
Christoph Knosalla, Hans B. Lehmkuhl, Jens Garbade, Christian Sieder, Stephan Hirt, Jörg Stypmann, Markus J. Barten, Uwe Schulz, Carola Grinninger, Andreas O. Doesch, Christoph Bara, Martina Porstner
Publikováno v:
American Journal of Transplantation. 19:3006-3017
In the 12-month, open-label MANDELA study, patients were randomized at month 6 after heart transplantation to (i) convert to calcineurin inhibitor (CNI)-free immunosuppression with everolimus (EVR), mycophenolic acid and steroids (CNI-free, n=71), or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::416d2f3edd8979378d4844c0d151b6bc
https://doi.org/10.1111/ajt.15361
https://doi.org/10.1111/ajt.15361
Autor:
Jens Gottlieb, Joachim Müller-Quernheim, Vasiliki Bessa, Carmen Capusan, Martin Strüber, Claus Neurohr, Christoph Knosalla, Bjoern Sill, Martina Porstner, Heinrike Wilkens, Hubert Wirtz
Publikováno v:
American Journal of Transplantation
Calcineurin inhibitor (CNI) therapy after lung transplantation increases risk of kidney failure. Early everolimus‐based quadruple low CNI immunosuppression may improve renal function without compromising efficacy or safety. A prospective, randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427a5c6af5ba7f2ad224911a309cc49a
https://doi.org/10.1111/ajt.15251
https://doi.org/10.1111/ajt.15251
Autor:
Martina Porstner, Claudia Sommerer, Björn Nashan, Christiane Schiedel, Christine S. Falk, Frank Lehner, Oliver Witzke, Duska Dragun, Friedrich Thaiss, Stefanie Marx, Martina Sester, Christine Neudoerfl, Barbara Suwelack, Ingeborg A. Hauser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8efcc12628c426af2662bd9eb5ef888a
https://doi.org/10.1002/eji.202048855/v2/response1
https://doi.org/10.1002/eji.202048855/v2/response1
Autor:
Martin Zeier, Katharina Heller, Anja Mühlfeld, Rudolf P. Wüthrich, Michael Dürr, Hans Ulrich Klehr, Rolf A.K. Stahl, Ingeborg A. Hauser, Petra Reinke, Barbara Suwelack, Peter Wimmer, Manfred Stangl, Claudia Sommerer, Wolfgang Arns, Silvio Nadalin, Martina Porstner, Heiner Wolters, Christoph May, Oliver Witzke, Klemens Budde, Ute Eisenberger, Frank Lehner
Publikováno v:
Nieren- und Hochdruckkrankheiten. 46:105-117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4192e138420d87dfc18828c47034773
https://doi.org/10.5414/nhx01811
https://doi.org/10.5414/nhx01811
Autor:
Markus J, Barten, Stephan W, Hirt, Jens, Garbade, Christoph, Bara, Andreas O, Doesch, Christoph, Knosalla, Carola, Grinninger, Jörg, Stypmann, Christian, Sieder, Han B, Lehmkuhl, Martina, Porstner, Uwe, Schulz
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
In the 12-month, open-label MANDELA study, patients were randomized at month 6 after heart transplantation to (i) convert to calcineurin inhibitor (CNI)-free immunosuppression with everolimus (EVR), mycophenolic acid and steroids (CNI-free, n=71), or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c39d0cb02c7b3fd0ed1f2501b48ec5d9
https://pubmed.ncbi.nlm.nih.gov/31448528
https://pubmed.ncbi.nlm.nih.gov/31448528